Back

Jin Medical shares surge 17.33% after Huaxia Qiying acquisition plan

Verifying
  • Jin Medical announced plans to acquire Huaxia Qiying Technology through contractual control agreements.
  • $159.4 million transaction would be paid through 71.28 million new Class A ordinary shares.
  • Jin Medical shares rose 17.33% to $2.37 after Tuesday’s regular session.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.